CHRONIC BERYLLIUM DISEASE IN A PRECIOUS METAL REFINERY - CLINICAL EPIDEMIOLOGIC AND IMMUNOLOGICAL EVIDENCE FOR CONTINUING RISK FROM EXPOSURE TO LOW-LEVEL BERYLLIUM FUME

Publisher Website
Google Scholar
Abstract
Five workers at a precious metal refinery developed granulomatous lung disease between 1972 and 1985. The original diagnosis was sarcoidosis, but 4 of the workers were subsequently proved to have hypertensitivity to beryllium by in vitro proliferative responses of lymphocytes obtained by bronchoalveolar lavage. Review of medical records of coworkers and extensive industrial hygiene surveillance of the plant demonstrated that 4 cases occurred in the furnace area where air concentration of beryllium fume were consistently below the permissible exposure limit of 2 .mu.g/M3. A single case has been recognized from parts of the refinery where exposure to cold beryllium dust often exceeded the standard by as much as 20-fold. These data demonstrate that chronic beryllium disease still occurs and confirm the importance of specific immunologic testing in patients suspected of having sarcoidosis but with potential exposure to beryllium. The data raise concern about the adequacy of modern industrial controls, especially in the setting of exposure to highly respirable beryllium fume.